Evidence map›Paper›PMID 31257545›Full record

ArticleMolecular medicine reports2019

[Retracted] miR‑127 aggravates myocardial failure by promoting the TGF‑β1/Smad3 signaling.

Hainian Xu, Fengmei Li

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Hainian XuDepartment of Cardiovascular Internal Medicine, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.
Fengmei LiDepartment of Internal Medicine, Weifang Zuoshan Central Hospital, Weifang, Shandong 261041, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the publication of the above article, the authors have found that they are not able to reproduce certain of the results presented in their research. The authors have expressed their concern about the choice of cell line selected for their original experiments, which may account for why their results are no longer reproducible. As a consequence, the authors have requested that this article be retracted from the publication. Both authors on the paper agree to the retraction, and regret the inconvenience that this retraction will cause to the Editor and to the readership of the Journal. [the original article was published in Molecular Medicine Reports 18: 4839‑4846, 2018; DOI: 10.3892/mmr.2018.9514].

Identifiers

PMID31257545
PMCPMC6691260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.